Simplify Asset Management Inc. Has $6.40 Million Stock Position in CVS Health Corporation $CVS

Simplify Asset Management Inc. increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 80.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 84,926 shares of the pharmacy operator’s stock after purchasing an additional 37,960 shares during the period. CVS Health makes up approximately 0.1% of Simplify Asset Management Inc.’s investment portfolio, making the stock its 25th largest holding. Simplify Asset Management Inc.’s holdings in CVS Health were worth $6,403,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. Norges Bank bought a new stake in shares of CVS Health in the 2nd quarter valued at about $1,358,698,000. Invesco Ltd. increased its stake in CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after purchasing an additional 3,118,626 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its position in shares of CVS Health by 815.2% during the second quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock worth $183,701,000 after purchasing an additional 2,372,121 shares in the last quarter. Kingstone Capital Partners Texas LLC acquired a new position in shares of CVS Health in the 2nd quarter valued at $155,185,000. Finally, Jennison Associates LLC raised its stake in CVS Health by 111.7% during the 2nd quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock worth $276,895,000 after buying an additional 2,117,798 shares during the period. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Zacks Research lowered CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. UBS Group reissued an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Wells Fargo & Company lowered their target price on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a report on Thursday, November 13th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $94.67.

CVS Health Price Performance

NYSE:CVS opened at $79.96 on Tuesday. CVS Health Corporation has a 52-week low of $43.65 and a 52-week high of $85.15. The company has a market cap of $101.50 billion, a P/E ratio of 210.41, a P/E/G ratio of 0.79 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The stock’s 50-day simple moving average is $78.86 and its 200 day simple moving average is $73.11.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same period last year, the company earned $1.09 earnings per share. The business’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.